Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has floated a tender for Radiopharmaceutical PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan). The project location is USA and the tender is closing on 15 Aug 2024. The tender notice number is HT941024N0127, while the TOT Ref Number is 105667517. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Radiopharmaceutical PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)
Deadline : 15 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 105667517
Document Ref. No. : HT941024N0127
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Notice of Intent to Sole Source HT941024N0127
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND
IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), intends to award a firm fixed price supply purchase for Radiopharmaceutical PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) Injections for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD) in accordance with the Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.1061(b)(1)(i), only one source being available to meet the Government-s needs, to:
Advanced Accelerator Applications USA Inc.
Willow STMillburn, New Jersey
07041-1416, United States
The North American Industry Classification System (NAICS) code for this requirement is 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING - In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1300 (in employees). The Product Service Code (PSC) is 6505 - DRUGS AND BIOLOGICALS.
The objective of this sole source award is to procure Advanced Accelerator Applications USA Inc.
Radiopharmaceutical PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) injections for Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The Nuclear Medicine Division urgently requires PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) injections for emergency treatments.
Deliver By:
21 August 2024
Advanced Accelerator Applications USA Inc. is the only source that can meet the Government-s minimum requirements to provide the requested supplies and reagents mentioned above at NMCSD.
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data...
Active Contract Opportunity
Notice ID : HT941024N0127
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-07:00) PACIFIC STANDARD TIME, LOS ANGELES, USA
Original Published Date: Aug 12, 2024 02:17 pm PDT
Original Response Date: Aug 15, 2024 10:00 am PDT
Inactive Policy: Manual
Original Inactive Date: Aug 16, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: San Diego, CA 92134 USA
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google